"This innovative chemical approach can potentially make any intravenous drug able to be taken orally. It can also promote any drug crossing the blood-brain barrier. This will remarkably broaden ...

IV medication could be taken orally for range of cancer, Alzheimer's treatments. ScienceDaily . Retrieved April 22, 2025 from www.sciencedaily.com / releases / 2025 / 04 / 250421162822.htm ...

Purpose: The frequency of drug administration errors and incompatibilities between intravenous drugs before and after an intervention in an intensive care unit (ICU) is discussed. Methods ...

“This innovative chemical approach can potentially make any intravenous drug able to be taken orally,” said Robert A. Hromas, MD, FACP, dean of the Joe R. and Teresa Lozano Long School of ...

Close to 51,000 Canadians died from apparent opioid toxicity between January 2016 and September 2024, making the unregulated toxic drug supply one of the most pressing health issues in Canada. For ...

- Pivot to U.S.-based Supply Chain for Critical Input Materials Completed - STONY BROOK, NY / ACCESS Newswire / April 21, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the ...

Joe Ward-Wallace, the owner of South LA Cafe, said that when he tried to make a complaint about another LAPD officer, two officers assaulted and arrested him, then arrested him for assaulting an ...

the fact that there has never been clinical trial material and/or commercial drug product produced utilizing the LineaDNA and/or Linea IVT platforms, and various other factors detailed from time to ...

IV remdesivir has been shown to shorten recovery time in patients with COVID-19, but there have been reports of some side effects with the drug that could force treatment to be interrupted.

Although ATB stand as one of the most profound revolutions in medicine ... in addition to aggregate data from the adverse event database of the US Food and Drug Administration (FDA; n = 38,705 reports ...

The Rasmussen Reports daily Presidential Tracking Poll for Wednesday shows that 50% of Likely U.S. Voters approve of President Trump’s job performance. Forty-eight percent (48%) disapprove.